Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10301313 Polymorphs

Patent 10301313 was granted and assigned to Boehringer Ingelheim on May, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11919903 Polymorphs
0
Edits on 2 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11911387 Vasoprotective and cardioprotective antidiabetic therapy
0
Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+169 characters)
Article

Patent abstract

The invention relates to polymorphous crystal modifications of a DPP-IV inhibitor, the preparation thereof and the use thereof for preparing a medicament.

Edits on 19 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1030131300
Edits on 28 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Boehringer Ingelheim
Boehringer Ingelheim
0
Current Assignee
Boehringer Ingelheim
Boehringer Ingelheim
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
103013130
Date of Patent
May 28, 2019
0
Patent Application Number
157254260
Date Filed
October 5, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=103013130
Patent Citations
‌
US Patent 10023574 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
0
Patent Citations Received
‌
US Patent 10668074 Uses of DPP IV inhibitors
0
‌
US Patent 10973827 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
0
‌
US Patent 11033552 DPP IV inhibitor formulations
0
‌
US Patent 11291668 Uses of DPP IV inhibitors
0
Patent Primary Examiner
‌
Noble E Jarrell
0
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 11291668 Uses of DPP IV inhibitors
0
Edits on 4 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 10668074 Uses of DPP IV inhibitors
0
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Edits on 6 Oct, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Oct, 2022
Edits on 27 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Boehringer Ingelheim
Boehringer Ingelheim
0
Current Assignee
Boehringer Ingelheim
Boehringer Ingelheim
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
103013130
Date of Patent
May 28, 2019
0
Patent Application Number
157254260
Date Filed
October 5, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=103013130
Patent Citations
‌
US Patent 10023574 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
0
Patent Citations Received
‌
US Patent 10668074 Uses of DPP IV inhibitors
0
‌
US Patent 10973827 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
0
‌
US Patent 11033552 DPP IV inhibitor formulations
0
‌
US Patent 11291668 Uses of DPP IV inhibitors
0
Patent Primary Examiner
‌
Noble E Jarrell
0
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations Received
‌
US Patent 11291668 Uses of DPP IV inhibitors
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations Received
‌
US Patent 10668074 Uses of DPP IV inhibitors
0
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10301313
Edits on 6 Apr, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11291668 Uses of DPP IV inhibitors
Edits on 12 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11033552 DPP IV inhibitor formulations

Find more entities like US Patent 10301313 Polymorphs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo